Edition:
India

Virbac SA (VIRB.PA)

VIRB.PA on Paris Stock Exchange

163.80EUR
16 Aug 2019
Change (% chg)

-- (--)
Prev Close
€163.80
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
10,303
52-wk High
€187.40
52-wk Low
€109.00

About

Virbac SA is a France-based veterinarian pharmaceutical company that specializes in the development and production of vaccines and medicines for domestic animals and livestock. Its production centers are located in France, Australia, the United States, Mexico, Vietnam, Brazil and South Africa. Its development efforts focus... (more)

Overall

Beta: 1.01
Market Cap(Mil.): €1,048.79
Shares Outstanding(Mil.): 8.46
Dividend: --
Yield (%): --

Financials

  VIRB.PA Industry Sector
P/E (TTM): 29.47 29.89 32.67
EPS (TTM): 4.21 -- --
ROI: 3.67 14.89 14.48
ROE: 7.75 16.01 15.78

Virbac 2018 operating profit grows helped by U.S. market

March 18 French veterinary pharmaceutical company Virbac said 2018 operating profit before depreciation of assets arising from acquisitions grew by 9.6 percent, helped by a strong performance in the U.S. and all other countries except Chile.

18 Mar 2019
Reuters.com is improving our Quote page. Click here to take a look and let us know what you think.

Earnings vs. Estimates